CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference at 3:45 p.m. EST on November 18, 2009, in New York City.
